Implementation of ERAS Guidelines in Patients Undergoing CRS and HIPEC: Need for Multicentre Trial

Hubner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K . Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special.... Eur J Surg Oncol. 2020; 46(12):2311-2323. DOI: 10.1016/j.ejso.2020.08.006. View

Hubner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K . Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management. Eur J Surg Oncol. 2020; 46(12):2292-2310. DOI: 10.1016/j.ejso.2020.07.041. View

Robella M, Tonello M, Berchialla P, Sciannameo V, Ilari Civit A, Sommariva A . Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC: A Systematic Review and a Meta-Analysis. Cancers (Basel). 2023; 15(3). PMC: 9913706. DOI: 10.3390/cancers15030570. View

Charleux-Muller D, Fabacher T, Romain B, Meyer N, Brigand C, Delhorme J . Implementation of an enhanced recovery program for complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a referral center: a case control prospective study. Pleura Peritoneum. 2023; 8(1):11-18. PMC: 10067553. DOI: 10.1515/pp-2022-0133. View